Search - tctmd.com

Displaying 341 - 360 of 457

Sort: Relevancy | Date

News Features

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Caitlin E. Cox

June 17, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

News Daily News

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Michael O'Riordan

June 07, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2016

Shelley Wood

May 31, 2016

News Conference News EuroPCR 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

Yael L. Maxwell

May 20, 2016

Presentation EuroPCR 2016

First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation

Presenter: Danny Dvir

May 19, 2016

News Conference News EuroPCR 2016

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Caitlin E. Cox

May 17, 2016

News Industry News

St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology

May 16, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Industry News

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

April 07, 2016

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Conference News CRT 2016

Will the MitraClip and Other Gadgets Make Headway in Functional MR?

Shelley Wood

February 25, 2016

News Daily News

合并左主干病变时不应排除 TAVR

L.A. McKeown

February 22, 2016

News Daily News

La Enfermedad de Tronco Coronario Izdo. Co-existente No Debería de Descartar Intervenciones TAVR

L.A. McKeown

February 22, 2016

News Daily News

Coexisting Left Main Disease Should Not Rule Out TAVR

L.A. McKeown

February 22, 2016

News Industry News

LivaNova PLC Announces FDA Approval of Stented Heart Valve CROWN PRT™ for Aortic Valve Disease

January 31, 2016

News Daily News

Shift From Mechanical to Bioprosthetic Aortic Valves in Middle-Aged Patients Gets Boost in Analysis

Caitlin E. Cox

January 20, 2016

News Daily News

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

L.A. McKeown

December 21, 2015

Advertisement

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

TCTMD’s Top 10 Most Popular Stories for May 2016

Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You?

First Look at Long-term Durability of Transcatheter Heart Valves: Assessment of Valve Function up To 10-years After Implantation

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Will the MitraClip and Other Gadgets Make Headway in Functional MR?

合并左主干病变时不应排除 TAVR

La Enfermedad de Tronco Coronario Izdo. Co-existente No Debería de Descartar Intervenciones TAVR

Coexisting Left Main Disease Should Not Rule Out TAVR

LivaNova PLC Announces FDA Approval of Stented Heart Valve CROWN PRT™ for Aortic Valve Disease

Shift From Mechanical to Bioprosthetic Aortic Valves in Middle-Aged Patients Gets Boost in Analysis

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content